r Bronchopulmonary dysplasia is a disease of extreme prematurity that occurs when the immature lung is exposed to gas ventilation.
Introduction
Extreme prematurity remains a leading cause of neonatal morbidity and mortality in the developed world. Advances in neonatal intensive care have extended limits of viability to 22-23 weeks of gestation, although at the cost of major morbidities in survivors. Bronchopulmonary dysplasia (BPD), which is the most common morbidity in infants born before 28 weeks, is considered to be a consequence of an arrest of pulmonary development because of gas ventilation (Jobe, 1999; Jobe & Ikegami, 2001; Coalson, 2003; Baraldi et al. 2009; Greenough, 2012; Patel et al. 2015) . Thus, regardless of the ventilation strategy utilized, the incidence of BPD has not improved. It is clear that a more physiological approach is required to optimize outcomes in this very challenging population. In response to this need, we have developed an extra-uterine system for supporting extremely premature lambs (105-117 days of gestation, term 145-150 days; pulmonary developmental equivalent of a 23-24 week human fetus) that recapitulates the fetal milieu, obviating mechanical ventilation and promoting physiological lung and organ development. This system, which we call EXTEND (EXTra-uterine Environment for Neonatal Development), provides gas exchange via a pumpless arteriovenous (AV) oxygenator circuit and maintains the lamb in a closed, flexible, plastic incubator ('Biobag') containing warmed, continuously-circulated synthetic amniotic fluid. Recently, we reported physiological support of 105-117 day gestational age (GA) lambs for up to 28 days on EXTEND, with circuit flows and oxygen parameters closely approximating normal fetal levels (Partridge et al. 2017) .
Over the past 50 years, vascular access has been an obstacle for groups developing 'artificial placenta' technology, with long-term support generally limited by insufficient circuit flows and, ultimately, subphysiological oxygen delivery (Callaghan et al. 1965; Alexander et al. 1968; Zapol et al. 1969; Unno et al. 1993; Awad et al. 1995; Sakata et al. 1998; Pak et al. 2002; Reoma et al. 2009; Miura et al. 2012; Schoberer et al. 2014; Bryner et al. 2015; Miura et al. 2015) . As our system evolved, we experimented with three distinct AV cannulation strategies: carotid artery/jugular vein (CA/JV), carotid artery/umbilical vein (CA/UV) and umbilical artery (×2)/umbilical vein (UA/UV). In the present study, we compare circuit flow and pressure parameters for each of these cannulation strategies in the EXTEND model.
Methods

Ethical conduct
Experiments were approved by the Institutional Animal Care and Use Committee of Children's Hospital of Philadelphia Research Institute, operating under national guidelines put forth by the United States Department of Agriculture (USDA) and in compliance with the ethical principles of the Journal of Physiology. Time-dated pregnant Suffolk or Hampshire ewes were obtained from a USDA-approved vendor. All animals were reared and transported under conditions specified by the Unites States Animal Welfare Act. Ewes were housed for a minimum of 2 weeks prior to cannulation to allow for acclimation to the laboratory environment and human handling. Ewes had consistent access to food and water and were allowed to feed ad libitum until the night prior to the cannulation procedure, at which point they were fasted in anticipation of general anaesthesia and intubation. Ewes were anaesthetized with 15 mg kg −1 of I.M. ketamine and general anaesthesia was maintained with inhaled isoflurane (2-4% in O 2 ) and propofol (0.2-1.0 mg kg −1 min −1 ). At the conclusion of the cannulation procedure, anaesthetized ewes were killed by pentobarbital sodium injection (Virbac AH, Inc., Fort Worth, TX, USA). In total, we used 26 pregnant ewes and cannulated 35 fetuses weighing between 1.0 and 2.5 kg. Six fetal lambs were utilized for the CA/JV group, of which two were subsequently excluded as a result of their death during the cannulation procedure. Fifteen fetal lambs were utilized for the CA/UV group of which 10 were subsequently excluded (n = 2: death during cannulation, n = 2: urethral obstruction, n = 3: traumatic decannulation during run, n = 3: umbilical vein thrombosis). Fourteen fetal lambs were utilized for the UA/UV group of which six were subsequently excluded (n = 3: death during cannulation, n = 1: traumatic decannulation during run, n = 1: umbilical artery thrombosis, n = 1: iatrogenic air embolism). In total, 17 fetal lambs were included in the present study (GA 105-117 days, term 145-150 days).
Experimental groups
Groups were distinguished by cannulation strategy: (CA/JV) carotid artery outflow and jugular vein inflow (n = 4); (CA/UV) carotid artery outflow and umbilical vein inflow (n = 5); and (UA/UV) double umbilical artery outflow and umbilical vein inflow (n = 8). Cannula size was based on the largest cannula that was easily accommodated by the vessels. The eight UA/UV animals have been reported in extensive detail previously (Partridge et al. 2017) .
Cannulation technique
In all experiments, the anaesthetized ewe was placed supine on the operating table, prepped with betadine solution and draped in sterile fashion. Lower midline laparotomy was performed to expose the gravid uterus and a small hysterotomy was made to expose the fetus. Carotid artery and jugular vein cannulation in CA/JV and CA/UV lambs was performed via mid-cervical cutdown, with cannulas (arterial extracorporeal membrane oxygenation (ECMO) cannulas; Medtronic, Minneapolis, MN, USA) inserted to a depth of ß3 cm. Umbilical vein cannulation in CA/UV lambs was performed via umbilical cord cutdown, with cannulas inserted ß1-2 cm from the umbilical ring and advanced ß2 cm to the level of the abdominal fascia. Silk ties were secured to the cannulated vessels to prevent cannula displacement. A custom-made plastic silo was sutured to the abdominal wall at the umbilical ring to protect the cord-cannula interface from potential limb trauma. UA/UV cannulation was performed via direct cutdown, using custom-made cannulas inserted ß8 cm from the umbilical ring and advanced ß2 cm into the vessel, maintaining a length of umbilical cord between the tips of the cannulas and the abdominal cord insertion (Fig. 1A) . Small magnets were placed on the superior and inferior aspects of the Biobag to protect the native cord and cord-cannula interface from limb movements. Magnets were also placed around the periphery of the Biobag to prevent significant lateral or rotational body movements that could place excessive tension on the cord (Fig. 1B) .
Oxygenator circuit
The pumpless AV circuit consisted of a low-resistance hollow fibre oxygenator (Quadrox-ID Pediatric Oxygenator; Maquet, Rastatt, Germany) connected to ECMO cannulas (Medtronic) or custom-made umbilical cannulas via BIOLINE R -coated tubing (Maquet). Pressurized blood flow from the carotid artery (CA/JV or CA/UV) or umbilical arteries (UA/UV) entered the oxygenator inflow port and returned to the jugular vein (CA/JV) or umbilical vein (CA/UV or UA/UV) via the oxygenator outflow port. The total circuit priming volume was 81 mL of maternal blood. 
Lamb maintenance on EXTEND
All aspects of longitudinal care on EXTEND have been described previously (Partridge et al. 2017) . Lambs received continuous infusions of heparin (goal activated clotting time 160-200 s) and prostaglandin E 1 (0.1 µg kg min −1 ). Pre-membrane and post-membrane blood gases and oxygen saturation were monitored at least twice daily. Sweep gas supplied to the oxygenator was a blended mix of medical air, nitrogen and oxygen, titrated to maintain P aO 2 20-30 mmHg, P aCO 2 35-45 mmHg and post-membrane oxygen delivery ß20-25 mL kg min −1 . Buprenorphine (0.005 mg kg −1 I.V. every 3-5 h as needed) and/or propofol (0.1 to 0.5 mg kg −1 min −1 ) was administered during periods of perceived agitation (repetitive restless movements, excessive swallowing, tachycardia). Total parenteral nutrition was administered continuously throughout the duration of EXTEND support and consisted of predominantly dextrose and amino acids (TrophAmine R 10%; B. Braun Medical Inc., Bethlehem, PA, USA), with supplemental iron, lipids and electrolytes (Partridge et al. 2017) . Lambs were maintained on EXTEND for up to 28 days, with studies terminated before this end-point if circuit flows or physiological parameters were considered incompatible with survival. Animals were killed by a pentobarbital injection at the conclusion of the study period.
Haemodynamic monitoring
Circuit blood flow and pre-/post-oxygenator pressures were continuously recorded as described previously (HT110 Bypass Meter and HXL Tubing Flowsensor; Transonic Systems Inc.; LabChart 7, ADInstruments Inc.) (Partridge et al. 2017) . Mean pre-and post-oxygenator pressures were calculated as 1/3 systolic + 2/3 diastolic (mmHg). The flow:pressure ratio, a measure of post-oxygenator resistance, was calculated as circuit blood flow/mean post-oxygenator pressure. 'Flow interruption' was defined as any period of circuit flow below 50% of mean flow for the flanking 2 h interval. Frequency and duration of flow interruptions was calculated using LabChart. To confirm the accuracy and validity of this digital flow interruption analysis, chart records were randomly selected and intervals of flow data were manually reviewed for comparison with LabChart flow interruption measurements over corresponding intervals. There was strong correlation between manual and digital data and, accordingly, LabChart was used to measure flow interruptions for all lambs in the present study.
Weight-adjusted calculations
The growth rate of lambs during studies was assumed to be exponential and derived from the measured body weight at the start and end of each run (according to the formula: y = ae bx , where y is the estimated body weight, x is the duration of run in days, a is the measured starting weight, b is the growth rate in kg kg -1 day -1 and e is a mathematical constant that is the base of the natural logarithm). Estimated daily weights were extrapolated from the exponential growth rate calculated for each lamb, and used for determining weight-adjusted flow rates.
Statistical analysis
Haemodynamic parameters (circuit flow, mean premembrane pressure, circuit flow:mean post-membrane pressure ratio) were averaged over 12 h and compared between groups using between-group (treatment) ANOVA. When significant differences between means were detected, multiple comparison analysis was performed using the least significant difference test in SPSS, version 23 (IBM Corp., Armonk, NY, USA). In UA/UV lambs, the change over time in circuit flow and flow:pressure ratio was analysed using within-group ANOVA or the Friedman test. Initial GA and weight at cannulation were compared between groups using Student's unpaired t test in SPSS. P < 0.05 was considered statistically significant. All data are presented as the mean ± SEM.
Results
GA and cannula size (Table 1)
There was no significant difference in starting GA (P = 0.76) or starting weight (P = 0.51) between groups. Lambs undergoing CA cannulation received one 8 Fr arterial cannula and one 8 Fr or 10 Fr venous cannula. CA/UV lambs had significantly higher weight-adjusted circuit flows than CA/JV lambs (P = 0.045) (Fig. 2) . There was no significant difference in pre-membrane circuit pressures between CA/JV and CA/UV groups (P = 0.92) (Fig. 3A) . Compared to CA/UV lambs, UA/UV lambs had significantly higher weight-adjusted circuit flows (P < 0.01) (Fig. 2) and mean pre-membrane circuit pressures (P < 0.01) (Fig. 3A) . Lambs with two 12 Fr UA cannulas had significantly higher pre-membrane circuit pressures than lambs with one 8 Fr CA cannula (P < 0.01) (Fig. 3B ). Although flow:post-membrane pressure ratio was not significantly higher in CA/UV lambs compared to CA/JV lambs (P = 0.24) or in UA/UV lambs compared to CA/UV lambs (P = 0.15), the flow:post-membrane pressure ratio was significantly higher in lambs with 12 Fr UV vs. 10 Fr UV cannulas (P = 0.01) (Fig. 4) . In the UA/UV group, weight-adjusted circuit flows declined gradually but significantly over the duration of EXTEND support (P < 0.001) (Fig. 2) and flow:pressure ratio declined significantly after 300 h on circuit (P < 0.001) (Fig. 4A ).
Duration on EXTEND (Fig. 4C and Table 1)
Mean duration of run was 177 ± 49 h in CA/JV lambs (range 103-321 h), 477 ± 50 h in CA/UV lambs (range 310-618 h) and 602 ± 30 h in UA/UV lambs (range 468-678 h) (P < 0.001) ( Table 1 ). All CA/JV lambs developed significant skin oedema within the first 72 h, whereas skin oedema was not seen in CA/UV and UA/UV lambs (with the exception of transient self-resolving oedema in UA/UV lambs 3 and 6). In the UA/UV group, six lambs survived over 600 h and two lambs survived 450-500 h on EXTEND, with a relatively early decline in flow:pressure ratio being observed in this latter subset (UA/UV lambs 4 and 6) (Fig. 4C ).
Flow interruptions (Table 2)
The mean number of flow interruptions per day was significantly different between groups: 89.3 flow interruptions per day in CA/JV lambs, 40.8 flow interruptions per day in CA/UV lambs and 1.7 flow interruptions per day in UA/UV lambs (P = 0.020). There were no significant between-group differences in the mean duration of individual interruptions. Cumulative proportion of interrupted flow was significantly lower in the UA/UV group compared to the CA/UV group (P < 0.01).
Discussion
The present study compared circuit flow and pressure parameters across different cannulation strategies in premature lambs maintained on EXTEND. Umbilical vessel cannulation (double umbilical artery and single umbilical vein) maximized weight-adjusted circuit flows, pre-membrane pressures and flow:post-membrane pressure ratio compared to CA/JV cannulation and CA/UV cannulation (Figs 2-4 and Table 1 ). Umbilical vessel cannulation was also associated with an improved circuit flow stability, as indicated by a significantly lower frequency of flow interruptions in UA/UV lambs ( Table 2) . As we transitioned stepwise from cervical to umbilical vessel access, we were able to quantify how umbilical vein and, ultimately, umbilical artery cannulation affected flow and pressure parameters on the pumpless circuit.
Analogous to the umbilical-placental circulation in utero, the oxygenator circuit on EXTEND is a high-volume AV shunt in parallel with the systemic circulation. As dictated by Ohm's law, circuit flow is inversely proportional to resistance and directly proportional to the AV pressure gradient. Circuit pressure measured at the pre-oxygenator and post-oxygenator membrane reflects both driving pressure (i.e. the pressure of blood reaching the oxygenator circuit) and post-membrane factors, including post-membrane resistance and central venous pressure. In the absence of direct systemic arterial and venous pressure measurements, we formulated a parameter that estimates the relative contribution of post-membrane resistance and/or central venous pressure to measured circuit pressures: the flow:pressure ratio.
Because the relationship between driving pressure and circuit flow is linear, the ratio of circuit flow to mean circuit pressure at a specific point on the EXTEND circuit (we chose the post-membrane pressure transducer) reflects the relative contribution of downstream resistance to measured circuit pressures (downstream resistors include post-membrane tubing, venous cannula, umbilical vein, ductus venosus, liver and central venous circulation). A higher flow:pressure ratio at the post-membrane transducer indicates a relatively low contribution of postmembrane resistors to measured pressures, whereas a lower flow:pressure ratio indicates a relatively high contribution of post-membrane resistors to measured pressures. Accordingly, we used the flow:pressure ratio to estimate the relative extent of post-membrane resistance and/or pressure on EXTEND (without directly measuring venous pressures). Driving pressure across the AV circuit on EXTEND is a function of systemic arterial pressure and the resistance between the systemic circulation and the circuit itself (the resistance across the cannulated arteries). Although the umbilical arteries comprise the most physiological conduit for extracorporeal support of the preterm neonate, attempts to cannulate the umbilical vessels for 'artificial placenta' inflow over the past 50 years have produced limited and progressively declining driving pressures and inadequate circuit flows. Researchers have employed several strategies aiming to circumvent the inherent spasticity of umbilical vessels, such as using continuous paralytics to minimize flow-limiting movement, inserting umbilical cannulas to the depth of the abdominal aorta and incorporating pumps to augment flow, often avoiding the umbilical arteries altogether (Callaghan et al. 1965; Alexander et al. 1968; Zapol et al. 1969; Unno et al. 1993; Awad et al. 1995; Sakata et al. 1998; Pak et al. 2002; Reoma et al. 2009; Miura et al. 2012; Schoberer et al. 2014; Bryner et al. 2015; Miura et al. 2015) . Although many of these approaches have supported long-term extra-uterine runs in premature animal models, none have achieved physiological 'placental' flows. Such substantial departures from in utero physiology are not optimal for clinical application, where the goal is to replicate normal fetal growth and development.
Our initial strategy was to cannulate the carotid artery and jugular vein because this technique was familiar based on experience with conventional ECMO and avoided the risks of umbilical vessel spasm and umbilical cannula erosion. We achieved excellent results with this cannulation strategy in late GA lambs (>120 days; data not shown), with a mean survival of 346 h and with one lamb successfully transitioning from the incubator to normal postnatal life (Partridge et al. 2017) . However, when we attempted CA/JV cannulation in four 110 day GA lambs (with lungs developmentally equivalent to 23 week human fetuses), all developed declining circuit flows and, ultimately, fulminant hydrops, with mean circuit runs limited to 177 h. Although we were not yet capable of routine echocardiographic assessment, the low circuit flow:pressure ratio in CA/JV lambs was indicative of a relatively high post-membrane resistance, which, in the presence of hydrops, strongly suggested right heart failure with elevated central venous pressures.
Presumed cardiac failure in CA/JV lambs highlighted important differences between the CA/JV circuit and normal in utero physiology. Cord blood returning to the venous circulation in utero is at a relatively low pressure after traversing placental resistance vessels (umbilical vein pressure reported as 6 mmHg in late gestation catheterized fetal lambs) (Berman et al. 1976) , whereas circuit blood returning to the venous circulation on EXTEND is inevitably at higher pressure because of the inherently low resistance of the oxygenator (see post-membrane pressures in Table 1 ). In CA/JV lambs with pressurized circuit blood entering the jugular vein, the direction of blood return may have placed additional strain on the premature right heart and central venous system. In utero, the vast majority of blood returning via the superior vena cava remains on the right side of the heart rather than crossing the foramen ovale (Rudolph & Heymann, 1967; Kiserud et al. 1992; Schmidt et al. 1996) . Accordingly, hydrops in CA/JV lambs may have been a result of inadequate right heart offloading in the setting of pressurized inflow to the jugular vein. In CA/UV lambs, we cannulated the umbilical vein (with the tip of the cannula beyond the umbilical fascia) to establish a more physiological venous return, aiming to improve shunting of circuit blood and the distribution of circuit pressures across the foramen ovale.
CA/UV lambs (106-113 days GA) exhibited no overt evidence for heart failure and survived significantly longer on circuit than CA/JV lambs, with all runs except one exceeding 450 h (one lamb died earlier in the setting of oxygenator dysfunction). Despite no significant differences in mean circuit pressures between CA/JV and CA/UV groups, umbilical vein cannulation translated into significantly higher circuit flows, suggesting improved post-membrane haemodynamics. Flow:pressure ratio, which was initially comparable between groups, precipitously declined in lambs with 10 Fr jugular vein cannulas but remained stable in lambs with 10 Fr umbilical vein cannulas ( Fig. 4B and Table 1 ). Although we were not yet performing routine echocardiographic assessment, we postulate that the restoration of physiological blood return via the umbilical vein facilitated shunting across the foramen ovale and, ultimately, offloaded the right heart in lambs with CA/UV cannulation. Longer circuit runs notwithstanding, flows in CA/UV lambs hovered well below the typical umbilical flow range in utero (150-200 mL kg −1 min −1 ) (Berman et al. 1976) , resulting in subphysiological oxygen delivery despite various compensatory efforts (Partridge et al. 2017) . Relatively low mean circuit pressures in CA/JV and CA/UV lambs (ranging from 22 to 35 mmHg, compared to umbilical artery pressures ranging from 40 to 55 mmHg in age-matched fetal lambs) (Rudolph & Heymann, 1970) reflected the inherently limited carotid flow and prompted our transition to double umbilical artery cannulation. Umbilical vessels, which are larger-caliber than cervical vessels at any given GA, accommodated larger-bore cannulas and maximized driving pressures to the pumpless circuit (Fig. 3) . UA/UV lambs had significantly higher circuit pressures and weight-adjusted flows, a function of inherently higher flows in the umbilical arteries and double arterial access with 12 Fr cannulas as opposed to single arterial access with an 8 Fr cannula in the CA/JV and CA/UV groups (Figs 3 and 4 and Table 1 ). The notion that double arterial cannulation augments circuit flow in a pumpless AV circuit was previously proposed by Awad et al. (1995) and our results corroborate their observations.
Despite the favourable caliber of umbilical vessels, umbilical cannulation has traditionally failed to support adequate circuit flows in previous 'artificial placenta' models (Callaghan et al. 1965; Alexander et al. 1968; Zapol et al. 1969; Unno et al. 1993; Awad et al. 1995; Sakata et al. 1998; Pak et al. 2002; Reoma et al. 2009; Miura et al. 2012; Schoberer et al. 2014; Bryner et al. 2015; Miura et al. 2015) . In light of these suboptimal outcomes, we devised several strategies to obviate vascular complications and maximize longitudinal circuit flow in UA/UV lambs. The potential for umbilical vessel spasm during the cannulation procedure was mitigated by precise surgical technique, topical papaverine administration, limited cannula insertion depth (ß2 cm) and maintaining low venous P O 2 . Overall cannula length was kept short to minimize resistance. Preserving a length of native umbilical cord helped us stabilize the cord-cannula interface, which was a critical step towards sustaining long-term, near-physiological circuit flows. To maintain the optimal orientation of cannulas within the umbilical vessels, we incorporated a specialized 'chimney' port to hold the cannulas in fixed position, with magnets around the cord to prevent limb trauma and, when necessary, magnets around the periphery of the Biobag to restrict lateral and rotational lamb movement and prevent excessive tension on the cord (Fig. 1) .
Although double arterial access significantly increased driving pressures in the UA/UV group, these lambs also demonstrated progressive improvement in venous flow dynamics, predominantly attributable to using a larger diameter venous cannula. Although a higher flow:pressure ratio in UA/UV lambs relative to other cannulation strategies was not statistically significant, the flow:pressure ratio was significantly higher in lambs with 12 Fr as opposed to 10 Fr umbilical vein cannulas ( Fig. 4B and Table 1 ). In addition, improved mechanical stability of the cord-cannula interface in UA/UV lambs may have reduced resistance to flow at the venous cannula outlet, thereby further optimizing flow:pressure ratio.
UA/UV lambs had significantly fewer flow interruptions (Table 2) , a testament to shifting the cannula-vessel interface away from the body by maintaining a length of native cord. In CA/JV and CA/UV lambs with cannulas advanced in the carotid vessel or to the level of the abdominal fascia, low flows often coincided with neck and body movements because any change in body position inevitably altered the orientation of cannulas at the cannula-vessel interface. By contrast, UA/UV lambs were able to move without significant flow disturbance because the body position had a minimal effect on cannulas within the stabilized cord. UA/UV lambs averaged two flow interruptions per day, compared to over 40 interruptions per day in CA/UV lambs and over 80 per day in CA/JV lambs (with no significant differences in mean duration of each interruption, averaging between 7 and 10 s). In addition to reducing flow interruptions, UA/UV cannulation dramatically reduced the risk of a decannulation event and, ultimately, allowed for discontinuation of all sedation, which is a major advantage for future clinical application.
Although UA/UV cannulation provides superior flows and flow dynamics relative to CA/JV or CA/UV cannulation, the umbilical model is not without limitations. In UA/UV lambs, we consistently observed gradually declining weight-adjusted circuit flows with time (P < 0.001) from ß200 mL kg −1 min −1 at the start of the run to ß150 mL kg −1 min −1 after 500 h on circuit. To maintain near-physiological oxygen delivery in the setting of declining circuit flows, we increased post-membrane oxygen saturation (to 100% by the end of the run in several lambs) and transfused adult blood or administered erythropoietin to achieve supraphysiological hemoglobin concentrations (Partridge et al. 2017) . Although effective for maintaining oxygen delivery, these compensatory measures may affect ductus venosus and intracardiac shunting, hepatic and pulmonary blood flows, blood viscosity, and thrombotic potential, and their implications require further investigation. Moreover, we do not completely understand why weight-adjusted circuit flows consistently decline with time on EXTEND. Systolic heart failure does not appear to be responsible, with the echocardiographic data in UA/UV lambs demonstrating stable combined cardiac output for the duration of EXTEND runs but a progressive and statistically significant reduction in the fraction of cardiac J Physiol 596.9 output entering the umbilical circuit (Partridge et al. 2017) . Progressive resistance across the oxygenator as a result of thrombotic deposition on oxygenator membranes may affect blood flow to the circuit, although there was no statistically significant longitudinal change in oxygenator resistance (data not shown). We did observe a significant decline in flow:post-membrane pressure ratio after 300 h, suggesting that post-membrane factors contribute to impaired circuit flows as runs progress.
Although the flow:pressure ratio is an important clinical parameter for assessing relative post-membrane flow dynamics on EXTEND, it cannot distinguish between resistance (post-membrane mechanical obstruction to flow) and venous pressure (central venous hypertension). In UA/UV lambs, the flow:pressure ratio generally peaked ß300 h into the run and declined thereafter until the end of the run (P < 0.001). Two UA/UV lambs demonstrated a more precipitous decline in flow:pressure ratio after ß300 h and, ultimately, required study termination after 450-500 h on circuit (Fig. 4) . A consistently declining flow:pressure ratio after 300 h suggests impaired post-membrane flow, although it remains unclear whether this pattern is primarily attributable to mechanical changes at the cord-cannula interface, umbilical vessel remodelling, high central venous pressures or some other combination of factors. We have not directly measured resistance across the post-membrane circulation and so cannot comment on whether changes in post-membrane resistance (at the level of the umbilicus, the umbilical vein, the ductus venosus or the liver) affect longitudinal circuit flows. In light of the inherently low-resistance oxygenator in our system (Partridge et al. 2017) , postmembrane blood returns to the venous circulation at supraphysiological pressures relative to umbilicoplacental venous return in utero (Table 1) ; however, without indwelling vascular catheters to measure systemic arterial and venous pressures, we can only speculate as to how this pressurized blood return affects cardiovascular physiology. We have observed normal central venous pressures during short-term studies in age-matched EXTEND lambs with jugular venous catheters (data not shown) but, to this point, we have not measured systemic pressures over the full 4 week duration of circuit runs. There has been no consistent echocardiographic evidence for heart failure in UA/UV lambs (Partridge et al. 2017) , with stable cardiac outputs and transient, self-resolving skin oedema. The two UA/UV lambs with relatively early declines in flow:pressure ratio did have signs of relatively higher central venous pressure on echocardiography (data not shown), although circumstances unique to these lambs probably contributed (lamb 4 developed oxygenator failure with high circuit resistance and lamb 6 swallowed excessively with resultant fluid overload). To better understand the systemic underpinnings of circuit flow and pressure measurements, additional studies are necessary in which we directly catheterize EXTEND fetal lambs for continuous systemic pressure measurements and correlation with echocardiographic findings. Ultimately, the flow:pressure ratio will be an important non-invasive means of assessing and optimizing circuit flow dynamics on EXTEND.
Conclusions
The findings of the present study show that umbilical vessel cannulation (at a distance from the umbilical ring) optimizes circuit pressures, circuit flows and venous pressure dynamics on EXTEND relative to CA/JV and CA/UV cannulation. Despite concerns about the inherent spasticity of umbilical vessels, UA/UV cannulation supported significantly longer runs (up to 4 weeks) with significantly fewer flow interruptions than other strategies. By contrast to previous experimental work directed toward an 'artificial placenta,' we have demonstrated that a pumpless AV circuit connected via umbilical vessel cannulation within a fluid environment is capable of supporting prolonged physiological umbilical flow. Achieving adequate blood flow to the oxygenator allows normal oxygen delivery with the maintenance of normal fetal oxygen saturation (Partridge et al. 2017) , which is a critical step toward physiological extra-uterine support of the extremely premature human infant.
